GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monogram Technologies Inc (NAS:MGRM) » Definitions » Earnings per Share (Diluted)

Monogram Technologies (Monogram Technologies) Earnings per Share (Diluted) : $-0.50 (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Monogram Technologies Earnings per Share (Diluted)?

Monogram Technologies's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-0.11. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.50.

Monogram Technologies's EPS (Basic) for the three months ended in Mar. 2024 was $-0.11. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.50.

Monogram Technologies's EPS without NRI for the three months ended in Mar. 2024 was $-0.11. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.62.

During the past 3 years, the average EPS without NRIGrowth Rate was -50.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -93.40% per year.

During the past 7 years, Monogram Technologies's highest 3-Year average EPS without NRI Growth Rate was -50.80% per year. The lowest was -143.50% per year. And the median was -98.70% per year.


Monogram Technologies Earnings per Share (Diluted) Historical Data

The historical data trend for Monogram Technologies's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monogram Technologies Earnings per Share (Diluted) Chart

Monogram Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial -0.06 -0.29 -0.38 -0.44 -0.61

Monogram Technologies Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.27 -0.03 -0.09 -0.11

Competitive Comparison of Monogram Technologies's Earnings per Share (Diluted)

For the Medical Devices subindustry, Monogram Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monogram Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Monogram Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Monogram Technologies's PE Ratio falls into.



Monogram Technologies Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Monogram Technologies's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-13.745-0)/22.409
=-0.61

Monogram Technologies's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-3.507-0)/31.536
=-0.11

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Monogram Technologies  (NAS:MGRM) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Monogram Technologies Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Monogram Technologies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Monogram Technologies (Monogram Technologies) Business Description

Traded in Other Exchanges
Address
3913 Todd Lane, Suite 307, Austin, TX, USA, 78744
Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Executives
Paul H Riss director
Noel Knape officer: Chief Financial Officer 3913 TODD LANE, AUSTIN TX 78744
Benjamin Sexson director, 10 percent owner, officer: Chief Executive Officer 3913 TODD LANE, AUSTIN TX 78744
Noel Goddard director 3913 TODD LANE, AUSTIN TX 78744
Kamran Shamaei officer: Chief Technology Officer 3913 TODD LANE, AUSTIN TX 78744
Douglas Unis director 3913 TODD LANE, AUSTIN TX 78744